Clinical trial
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent…
NCT00494338 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00494338 |
|---|---|
| Title | Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer |
| Official title | A Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Prostate Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel |
| Enrollment | 6 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Jun 29, 2007 |
| Last update posted | Oct 1, 2009 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: